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necessary before evaluation in randomised
clinical trials?
Trishna Rathod1*, John Belcher2, Alan A Montgomery3, Chris Salisbury4 and Nadine E Foster1Abstract
Background: Most randomised clinical trials (RCTs) testing a new health service do not allow a run-in period of
consolidation before evaluating the new approach. Consequently, health professionals involved may feel
insufficiently familiar or confident, or that new processes or systems that are integral to the service are insufficiently
embedded in routine care prior to definitive evaluation in a RCT. This study aimed to determine the optimal run-in
period for a new physiotherapy-led telephone assessment and treatment service known as PhysioDirect and
whether a run-in was needed prior to evaluating outcomes in an RCT.
Methods: The PhysioDirect trial assessed whether PhysioDirect was as effective as usual care. Prior to the main trial,
a run-in of up to 12 weeks was permitted to facilitate physiotherapists to become confident in delivering the new
service. Outcomes collected from the run-in and main trial were length of telephone calls within the PhysioDirect
service and patients’ physical function (SF-36v2 questionnaire) and Measure Yourself Medical Outcome Profile v2
collected at baseline and six months. Joinpoint regression determined how long it had taken call times to stabilise.
Analysis of covariance determined whether patients’ physical function at six months changed from the run-in to
the main trial.
Results: Mean PhysioDirect call times (minutes) were higher in the run-in (31 (SD: 12.6)) than in the main trial
(25 (SD: 11.6)). Each physiotherapist needed to answer 42 (95% CI: 20,56) calls for their mean call time to stabilise
at 25 minutes per call; this took a minimum of seven weeks. For patients’ physical function, PhysioDirect was equally
clinically effective as usual care during both the run-in (0.17 (95% CI: -0.91,1.24)) and main trial (-0.01 (95%
CI: -0.80,0.79)).
Conclusions: A run-in was not needed in a large trial testing PhysioDirect services in terms of patient outcomes. A
learning curve was evident in the process measure of telephone call length. This decreased during the run-in and
stabilised prior to commencement of the main trial. Future trials should build in a run-in if it is anticipated that
learning would have an effect on patient outcome.
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In randomised clinical trials (RCTs) within health ser-
vices research, it is common that new or amended ser-
vices are developed, implemented and evaluated almost
immediately. This may not be ideal as new services may
benefit from amendments based on early learning and
the service might demonstrate improved performance
over time [1], as new processes and practices become
embedded, known as a learning curve. Consequently, an
immediate evaluation of the new service as part of an
RCT may be misleading and subject to bias.
If it is known or suspected that a learning curve may
affect a new service or treatment approach, a run-in
period used as a period of consolidation is suggested
prior to recruitment to the RCT [2]. Such a run-in
period allows healthcare practitioners to become suffi-
ciently familiar in delivery of the new service and for
new processes to become embedded in routine care,
thus allowing the service to reach a stable and efficient
level of delivery before evaluation. By way of example, a
cardiopulmonary resuscitation study had a three month
run-in period for practitioners to become familiar in
using a new monitor defibrillator prior to the start of the
formal RCT evaluation [3].
Although run-in periods are used for a variety of rea-
sons [4-6] using them as a period of consolidation ap-
pears to be relatively rare in health services research as
they can require considerable time and resource prior to
a full RCT. As a result, clinical research teams may be
hesitant to incorporate run-in periods in the timeline of
their RCTs. Very little is known about whether run-in
periods of consolidation are necessary prior to RCTs of
new services or treatment approaches or whether they
have an impact on either key intervention processes or
clinical outcomes.
The aims of this study were:
1. To determine the optimal run-in period of consoli-
dation for a new primary care service prior to the
main RCT.
2. To determine if the provision of a run-in period of
consolidation was needed before patient and process
outcomes were evaluated.
Methods
PhysioDirect trial
Musculoskeletal problems are painful and disabling and
can cause poor health; such individuals are often referred
to physiotherapy for treatment [7]. Access to physiotherapy
in the UK NHS has traditionally been associated with long
waiting times for an initial consultation, with delays of up
to several months [7]. Consequently, many patients fail to
attend their consultation or the consultation provides little
benefit as patients are seen too late [8]. In response towaiting list pressures, new physiotherapy-led telephone as-
sessment and treatment services known as PhysioDirect
have been developed and are available in some areas of the
UK [8]. The MRC PhysioDirect trial was a multi-centre
pragmatic equivalence RCT designed to test the clinical
and cost-effectiveness of PhysioDirect services. Patients
were randomised in a 2:1 ratio to PhysioDirect or usual
physiotherapy care where patients were placed onto waiting
lists and waited for the next available appointment [9]. The
trial incorporated a run-in period of consolidation of be-
tween seven and twelve weeks varying between the partici-
pating primary care trusts (PCTs) prior to the main trial.
The data from this trial will be used for the purposes of this
paper.
Multisite research ethics approval for the PhysioDirect
trial was obtained from Southmead research ethics com-
mittee, reference 08/H0102/95. All participants gave in-
formed written consent.
In the PhysioDirect trial, in the PhysioDirect service,
patients wishing to access physiotherapy treatment could
telephone a senior physiotherapist for an initial assess-
ment followed by appropriate advice over the telephone
supplemented by leaflets through the post. Physiothera-
pists used bespoke software to provide a template for
their assessment and as an electronic medical record of
the consultation. Patients were invited to telephone the
service two to four weeks later to report progress. Pa-
tients were invited to a face to face consultation if they
needed urgent care or if their condition failed to
improve.
A new PhysioDirect service was set up in four PCTs.
As PhysioDirect was a new service, eight physiothera-
pists from each PCT (32 in total) undertook a structured
training programme and had to be certified as compe-
tent to deliver the service, however it was expected the
physiotherapists would require a period of practice and
consolidation before they became familiar with deliver-
ing the new service. To ensure the PhysioDirect service
was running efficiently prior to its formal evaluation in
the main RCT, the PhysioDirect trial operated in two
phases. The first phase was a run-in period of consolida-
tion which lasted 12, 10, 11 and 7 weeks for PCTs A, B,
C and D respectively. Patients recruited during this
phase were randomised to either the usual care arm
or to the PhysioDirect arm. The second phase was the
main trial which recruited and randomised a fresh set
of patients to the two arms. Patients randomised in
the run-in period were not included in the main trial
analysis, thus creating two separate datasets for ana-
lysis in this study. The run-in period allowed physio-
therapists to build their confidence and competence
in delivering the PhysioDirect service and to embed
key processes. In particular, it was anticipated that
the length of telephone calls would decrease as the
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patients by telephone and in using the PhysioDirect
software.
By comparing the data collected from the run-in
period with those from the main trial, we examined two
issues. First, whether the length of telephone consulta-
tions changed over time, as this could have important
implications for the cost-effectiveness of the PhysioDir-
ect service. Second, whether patients’ clinical outcomes
differed between those who were recruited in the run-in
period and main trial.
Outcomes
Key outcomes for this study include both process and
clinical outcomes. The key process outcome was the
length of the telephone call in the PhysioDirect service.
The date and call time of each telephone call made by a
patient to the PhysioDirect service and the physiotherap-
ist who handled the call was recorded. Only the partici-
pant’s initial call was used in the analysis as follow up
call times were shorter as patient details were already
known.
Two key clinical outcomes were used for the purposes
of this study. The first was the primary clinical outcome
for the trial, the physical component score (PCS), from
the SF-36v2 patient reported questionnaire of general
health. PCS is a generic measure of physical function
which is scored from 0 to 100 with lower scores indicating
worse physical function [10]. The second was the Measure
Yourself Medical Outcome Profile v2 (MYMOP2), which
is a patient generated score. Patients specified their symp-
toms and limitations for which they were referred to
physiotherapy. The follow-up questionnaire was tailored
to the patient’s specified symptoms and limitations in
order to assess change in those symptoms and limitations
[11]. These clinical outcomes were measured at baseline
before randomisation and six months later for patients in
both the run-in period and main trial.
Statistical analysis
Key process measure - telephone call time
It was envisaged that mean call time would initially be
high during the run-in period but would gradually de-
crease as the physiotherapists grew in confidence and
competence in using the new service. Call time was ex-
pected to stabilise at around 20 minutes based on the
experience of the team responsible for training physio-
therapists in the PhysioDirect service [12].
To investigate if, and when, call time had reached a
plateau, descriptive statistics compared mean call time
between the two phases. The two phases of the trial can
be viewed on one timeline as the main trial commenced
recruitment immediately after the run-in period thus
allowing the call time trend to be explored. The timelinewas defined from the date the first patient was referred
to physiotherapy and screened for eligibility for the trial
in the run-in period to the date that the last patient was
referred to physiotherapy in the main trial. Participating
PCTs’ timelines were not comparable as each PCT com-
menced recruitment at different times in the year.
Therefore within each PCT, patients were grouped into
weeks according to the date of their referral to physio-
therapy from the start of the run-in period. A four week
rolling mean call time plot illustrated whether there was
a trend in call times as patients were recruited to the
trial.
Modelling call time trend needs to detect changes in
gradient as it was expected physiotherapists’ call times
would shorten over time. Joinpoint regression analysis
detects these change points (known as a joinpoint) and
determines the gradient between joinpoints [13]. Using
the timeline described above assumes all physiothera-
pists had delivered the PhysioDirect service at approxi-
mately the same time (that is the start of the run-in
period) and had taken the same number of calls per
week therefore a different timeline was used. For each
physiotherapist, the call times of all their telephone calls
were ordered from the earliest date and time of the call.
Mean call times were calculated across the physiothera-
pists in order to represent the mean duration of their
first call, second call, third call, and so on. Specifying a
maximum of three joinpoints to be used in the model-
ling, three permutation tests using Monte Carlo
methods determined the optimal number of joinpoints
needed to describe the mean call time trend: i) testing
the null hypothesis of zero joinpoints against the alter-
native of three joinpoints, ii) testing one joinpoint
against three joinpoints, iii) testing two jointpoints
against three jointpoints [13]. If no joinpoints were iden-
tified, this would suggest the trend had no significant
changes of direction; if joinpoints were identified this
would suggest there were significant changes in direc-
tion which may correspond to when call time had
reached a plateau. To determine how long it had taken
physiotherapists’ call time to plateau, call times were
plotted against the week the patient was referred to
physiotherapy, thus identifying when call time had
stabilised.
Multilevel models [14] were used to model call time
taking into account the clustering effects from the
physiotherapists and PCTs; the call times within each
physiotherapist were ordered from the earliest date
and time of the call. The variance partition coefficient
(VPC) was calculated from the null model, which
is no adjustment for explanatory variables. This would
establish whether the variability in call times was at-
tributable at the PCT level or between physiothera-
pists within a PCT [15].
Table 1 Call time distribution
Mean (SD), number of telephone calls
Run-in period N = 759 Main trial N = 1236
PCT
A 31 (12.2), 190 23 (9.3), 395
B 29 (11.1), 181 27 (9.8), 290
C 38 (12.7), 255 30 (15.5), 298
D 23 (7.3), 133 19 (7.5), 253
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To investigate whether patients’ clinical outcomes for
those recruited in the run-in period differed to those re-
cruited in the main trial, summary statistics for physical
function (SF-36v2 PCS) and symptoms (MYMOP2) at
baseline and six months were described for both phases.
For each patient, their change in clinical outcome at six
months was calculated by subtracting their baseline
score from their six month score. A positive change in
physical function or a negative change in symptoms in-
dicates improvement in health at six months. Viewing
the two phases of the trial on one timeline, a four week
rolling mean plot for patients’ change in clinical out-
comes at six months showed whether patients recruited
in the run-in period had greater or smaller changes in
clinical outcomes compared to patients recruited in the
main trial.
An analysis of covariance (ANCOVA) compared mean
physical function at six months between the PhysioDir-
ect service and usual care (that is the treatment effect)
adjusting for baseline physical function, age, gender,
PCT and referral problem in the run-in period and the
main trial. The clinical effectiveness of the PhysioDirect
service and usual care were deemed equivalent if the
95% confidence interval from its treatment effect lay
between -2 and 2 points on the physical function scale
[9]. An independent t-test compared the treatment effect
from the run-in period to the main trial [16]. The
ANCOVA was repeated for symptoms at six months and
replacing baseline physical function with baseline symp-
toms, followed by the independent t-test. For the symp-
toms scale, a difference of no more than 0.5 points was
defined as demonstrating equivalence [17].
Longitudinal modelling [14] was used to model the dy-
namics of the clinical outcomes at six months for usual
care and PhysioDirect over time where time is week of
referral to physiotherapy. This would illustrate that pa-
tient clinical outcomes did not differ between patients
recruited within the same phase or between different
phases of the trial. The modelling adjusted for week of
patient referral, treatment and phase of the trial plus a
three way interaction term.
Joinpoint Regression Programme v4.0.1. [18] was used
for the joinpoint regression modelling and all other ana-
lyses were conducted in STATA v12 [19].
Results
Key process measure - telephone call time
Thirty-two senior physiotherapists delivered the Physio-
Direct service. Mean call time was higher in the run-in
period compared to the main trial (31 minutes (SD:
12.6) versus 25 minutes (SD: 11.6)) and the finding was
the same when stratified by PCT (Table 1). Figure 1shows a four week rolling mean plot for call time illus-
trating call time was initially high at 35 minutes per call
during the run-in period but gradually decreased over
time and eventually reached a plateau of approximately
25 minutes prior to patient recruitment to the main
trial.
The joinpoint regression model identified three sta-
tistically significant changes in the call time trend
(Figure 2). The first change occurred at 42 (95% CI: 20,
56) telephone calls hence each physiotherapist, re-
duced their call time by 0.21 minutes (12 seconds)
when they answered their subsequent call, with their
call time stabilising when they each had answered 42
calls. It took at least seven weeks from the start of the run-
in period for call times to stabilise. The second change oc-
curred at 139 (95% CI: 135, 145) calls and the third at 150
(95% CI: 148, 150); the change in call times in the third and
fourth periods may have been associated with a lack of calls
made to the service as the trial stopped recruitment to new
patients, and the standard error (SE) for the change in call
times is wide due to the small number of calls.
From the longitudinal modelling the VPCs were calcu-
lated. In total, 30% (95% CI: 25.8, 34.1) of the variation
in calls times was attributable at the PCT level which
rose to 41% (95% CI: 35.7, 45.8) between physiothera-
pists within a PCT.
Key clinical outcomes - physical function and symptom
change
There were 1,465 randomised patients in the run-in
period and 2,249 patients in the main trial. Patient char-
acteristics (age, gender and referral problem) (Table 2)
and clinical outcomes (Table 3) were similar between pa-
tients randomised to usual care and PhysioDirect in the
run-in period and the main trial.
By randomisation arm, Figure 3 and Figure 4 show the
rolling mean plot for the clinical outcomes as patients
were recruited to the trial. In usual care, although pa-
tients’ physical function and symptoms improved, their
clinical outcomes varied more at different stages of re-
cruitment compared to the PhysioDirect service where
the clinical outcomes were more consistent. This may be
associated with the smoothing effect of the larger sample
in the PhysioDirect arm.
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Figure 1 Call time trend. Means with 95% confidence intervals.
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PhysioDirect and usual care trial arms at six months was
0.17 (95% CI: -0.91, 1.24) for the run-in period and -0.01
(95% CI: -0.80, 0.79) for the main trial. The 95% confidence
intervals lies entirely between -2 and 2 points on the phys-
ical function scale suggesting PhysioDirect was as effective
as usual care in both the run-in period and the main trial.
An independent t-test performed between the two treat-
ment effects gave a difference of 0.17 (95% CI: -0.19, 1.53)
suggesting there was no significant difference in patients’0
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Figure 2 Identified changes in the call time trend using joinpoint reg
decreased by 0.21 minutes (12 seconds) when physiotherapists answered t
by 0.05 minutes (3 seconds); between 140 and 149 calls, call time decrease
increased by 4 minutes. SE: standard error.physical function achieved during the run-in period and
the main trial.
The difference in symptoms for the PhysioDirect service
compared to usual care at six months was 0.03 (95%
CI: -0.13, 0.20) for the run-in period and -0.02 (95%
CI: -0.16, 0.11) for the main trial. The 95% confidence inter-
vals lies entirely between -0.5 and 0.5 points on the symp-
toms scale suggesting PhysioDirect was as effective as usual
care in both the run-in period and the main trial. Perform-
ing an independent t-test between the two treatment effects80 100 120 140 160
elephone calls
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ression. Between 0 and 41 telephone calls, on average call time
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d by 1.01 minutes (60 seconds); between 151 and 152 calls, call time
Table 2 Baseline participant characteristics
Run-in period Main trial
Number of patients (%) Number of patients (%)
Usual care PhysioDirect Usual care PhysioDirect
N = 488 N = 977 N = 743 N = 1506
Agea 49.8 (15.9) 50.3 (16.0) 49.0 (16.3) 48.9 (16.0)
Gender:
Female 288 (59.0) 583 (59.7) 438 (59.0) 897 (59.6)
Male 200 (41.0) 394 (40.3) 305 (41.1) 609 (40.4)
Referral problem:
Cervical 63 (13.0) 116 (11.9) 89 (12.0) 185 (12.3)
Thoracic 6 (1.2) 19 (1.9) 13 (1.8) 35 (2.3)
Lumbar 139 (28.6) 292 (29.9) 203 (27.4) 412 (27.4)
Upper limb 104 (21.4) 201 (20.6) 174 (23.5) 351 (23.3)
Lower limb 147 (30.3) 302 (30.9) 225 (30.3) 450 (29.9)
Widespread pain 3 (0.6) 5 (0.5) 7 (0.9) 8 (0.5)
Multiple MSK 22 (4.5) 39 (4.0) 27 (3.6) 55 (3.7)
Other MSK 2 (0.4) 3 (0.3) 4 (0.5) 10 (0.7)
PCT:
A 128 (26.2) 256 (26.2) 251 (33.8) 499 (33.1)
B 118 (24.2) 224 (22.9) 165 (22.2) 348 (23.1)
C 159 (32.6) 342 (35.0) 174 (23.4) 353 (23.4)
D 83 (17.0) 155 (15.9) 153 (20.6) 306 (20.3)
MSK: musculoskeletal.
aMean (standard deviation) provided.
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ing no significant difference in patients’ clinical outcomes
from the run-in period and the main trial.
Longitudinal modelling of the clinical outcomes in
Figure 5 illustrates clinical outcomes at six months of
patients recruited in the run-in period did not differ to
patients recruited in the main trial nor had patient out-
comes differed to those recruited in different weeks
within a phase.Table 3 Distribution of clinical outcomes
Run-in period
Usual care Physio
Physical function
Baseline 36.5 (8.9), 486 37.2 (8
6 months 43.7 (10.6), 320 43.9 (10
Symptoms
Baseline 3.8 (1.0), 485 3.8 (1.0
6 months 2.2 (1.4), 317 2.3 (1.4
Mean (standard deviation), number of patients.Discussion
Summary of main findings
This study determined the optimal length of a run-in
period of consolidation within a trial testing a new primary
care service known as PhysioDirect, and whether the run-
in period was necessary before key clinical outcomes were
evaluated in the main trial.
Our key process outcome of telephone call time showed
that the physiotherapists operating the PhysioDirect serviceMain trial
Direct Usual care PhysioDirect
.9), 975 37.7 (8.6), 743 36.8 (8.9), 1504
.8), 613 44.2 (10.8), 629 43.5 (10.9), 1283
), 975 3.8 (1.0), 743 3.8 (1.0), 1504
), 610 2.4 (1.4), 518 2.4 (1.4), 1033
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Figure 3 Patients’ improvement in physical function (SF-36v2 PCS) at six months at different stages of recruitment. Means with 95%
confidence intervals.
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Figure 4 Patients’ improvement in symptoms using the Measure Yourself Medical Outcome Profile (MYMOP2) at six months at
different stages of recruitment. Means with 95% confidence intervals.
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skeletal pain patients but that over time their call times
reduced. Each physiotherapist needed to answer ap-
proximately 42 calls in order for their call time to sta-
bilise at around 25 minutes per patient. A seven week
run-in period would have been sufficient for call times
to stabilise rather than the longer run-in period used
in this trial.
Our results show that the differences in key patient
clinical outcomes between the PhysioDirect service and
usual care did not change from the run-in period to the
main trial. In both phases the new PhysioDirect service
was clearly as clinically effective as usual care. Patients
randomised to the PhysioDirect arm received the same
treatment effects regardless of when they were recruited
to the trial. This means that the overall evaluation of the
PhysioDirect service could have been based on combin-
ing patients from both the run-in period and the main
trial to generate more precise estimates.
Comparison with previous research
Run-in periods are used for a variety of reasons and may
be used to select which potential participants can be
randomised to RCTs. For example, Ulmer et al. [4] con-
ducted an RCT of a behavioural intervention which had
a one month run-in period to allow potential partici-
pants time prior to randomisation to reflect on whether
they would like to continue in the study. As a result the
RCT had a lower drop-out rate compared to the trial’s
pilot study which did not have a run-in period.Other studies have investigated the effect of the learn-
ing curve on the processes and clinical outcomes in tri-
als. Taekman et al. [20] showed that early recruitment
was associated with more protocol departures than later
recruitment but did not find changes in their key patient
outcome (mortality). Laterre et al. [21] found greater
mortality in participants randomised to the intervention
arm who were recruited early on in their ADDRESS and
PROWESS trials. Learning curves exist in surgical trials
where surgeons improve their performance of a new
technique; it has been suggested that the effect of the
learning curve can be controlled using post ad hoc stat-
istical methods [22].
Although previous research has shown the benefits of
run-in periods, no study appears to have investigated the
effect of a run-in period of consolidation on key process
measures and clinical outcomes when evaluating the ef-
fectiveness of a new health service. This may be because
previous studies have most likely not included a run-in
period, or they have not compared data between the
run-in and main trial period, or because the same out-
come measures were not collected in both phases.
Strengths and limitations
Although this study was not powered to detect whether
the difference in clinical outcomes between the Physio-
Direct service and usual care had changed from the run-
in period to the main trial, the PhysioDirect trial had
a large number of patients randomised in the run-in
period and in the main trial; was conducted in four
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sidering the size of the recruited samples in the run-in
period and the main trial, this may be the largest study
to investigate whether key process and patient outcomes
change from the run-in period to the main trial and
whether a run-in period is necessary.
The fact that the study was conducted over four cen-
tres enhances its generalisability. All physiotherapists
undertook the same structured training programme and
had to be certified as being competent to deliver the
PhysioDirect service and they all used the same tele-
phone assessment software to ensure consistency in the
way the PhysioDirect service was delivered. However the
study did identify some differences in mean call times
between the PCTs, which probably reflected other exter-
nal pressures on the services in each area.
Implications
The appropriate length of run-in period in a trial testing
new health services or treatment approach varies and is
dependent on the recruitment rate, randomisation allo-
cation and the training and support that health profes-
sionals are given. In a large RCT testing PhysioDirect
services, we have demonstrated that a shorter run-in
period of seven weeks would have been sufficient for key
processes to stabilise. This would have made it possible
to recruit and follow up fewer patients.
A learning curve in key processes associated with the
delivery of a new service can affect the analysis of its
cost-effectiveness. In the PhysioDirect service, physio-
therapists initially took longer over patient telephone
calls and this would have affected estimates of its run-
ning costs in the first few weeks of operation. Conclu-
sions about the cost-effectiveness of the PhysioDirect
service compared with usual care should only be based
on the main trial because including information from
the run-in period would inflate the PhysioDirect’s overall
costs and potential lead to incorrect conclusions. In fu-
ture trials the cost-effectiveness analysis of the new ser-
vice in its first few weeks of operation would be useful
in demonstrating the additional cost from the learning
curve.
The run-in period had insufficient power (63%) to detect
equivalence between usual care and the PhysioDirect ser-
vice as its main purpose was to act as a consolidation
period to embed the trial’s procedures. In retrospect, pa-
tients’ clinical outcomes did not change from the run-in
period to the main trial, therefore the two phases could
have been combined resulting in a shorter recruitment
period of 14 weeks to recruit 625 and 1,250 patients to
usual care and PhysioDirect respectively rather than a total
of 33 weeks used in the PhysioDirect trial. Future RCTs
could build in a run-in period and using similar methods
described here, investigate if process measures change overtime and determine when learning stabilises. Once deter-
mined, the main trial would commence recruiting the
remaining participants needed and the final analysis would
not acknowledge a portion of the data had come from the
run-in period which is an approach taken in an internal
pilot study [23]. Future trials could adopt this approach to
limit the extra resources needed in conducting a run-in
period as a shorter recruitment period would be required.
The PhysioDirect service was set up in four PCTs and
they had different lengths of run-in periods. It was decided
that each PCT should have a run-in period of at least four
to six weeks in order to test out all processes. The first
PCT to start the trial used the maximum 12 week run-in
period whilst subsequent PCTs required a shorter run-in
period as experiences from the first PCT were shared with
the other PCTs. Future trials conducted in several services
could use this example by allowing the first service team to
start the trial to have the longest run-in period and subse-
quent teams to have shorter run-in periods.
Conclusions
This study demonstrated that a learning curve existed in
the process of delivering a new primary care service
known as PhysioDirect. Although a twelve week run-in
period of consolidation was allowed for physiotherapists
to become competent in delivering the new service, a
shorter run-in period of seven weeks would have suf-
ficed for telephone call times to stabilise. Changes in key
patient clinical outcomes between PhysioDirect and
usual care were the same in the run-in period and in the
main trial therefore the PhysioDirect trial did not re-
quire a run-in period of consolidation for the purposes
of assessing the primary clinical outcome. Future trials
should build in a run-in period if it is anticipated learn-
ing would have an effect on patient outcomes and use
process measures and similar methods presented here to
identify when learning stabilises to maximise the effi-
ciency of their trial.
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